| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/14/2007 | CN1299832C Core for blood processing apparatus |
| 02/14/2007 | CN1299817C Oxidation reactor, method for producing (meth)acrylic acid or the like, and method for analyzing easily polymerizable compound |
| 02/14/2007 | CN1299759C Chinese medicine composition for treating dizziness and its preparing and quality control method |
| 02/14/2007 | CN1299643C Blood sugar level measuring method and apparatus |
| 02/13/2007 | US7177454 Automated detection of objects in a biological sample |
| 02/13/2007 | US7176697 Flexible probe for measuring moisture content in soil |
| 02/13/2007 | US7176682 Method and apparatus for detecting hydrocarbons with NMR logs in wells drilled with oil-based muds |
| 02/13/2007 | US7176345 Rodent model comprising genes coding hypoxia inducible factor (HIF) for detection of hypoxic tissue |
| 02/13/2007 | US7176299 Compounds |
| 02/13/2007 | US7176294 Transcription factor, BP1 |
| 02/13/2007 | US7176291 Using immunoglobulin transferase binding activity to diagnose cancer |
| 02/13/2007 | US7176290 Tau protein epitopes for use in the treatment of alzheimer's disease |
| 02/13/2007 | US7176287 Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins |
| 02/13/2007 | US7176285 Ligands for human protein histidine phosphatase (PHP1); identifying agonists and antagonists and treating conditions associated with PHPIP-120 imbalance with the identified compounds; cardiovascular disorders; autism; schizophrenia; antiarthritic and -carcinogenic agents; Bardet-Beidl Syndrome; anemia |
| 02/13/2007 | US7176283 Protease-activated receptor 3 and uses thereof |
| 02/13/2007 | US7176277 Conversion of apoptotic proteins |
| 02/13/2007 | US7176187 Fusion proteins based upon somatostatin receptors |
| 02/13/2007 | US7176185 A di, tri or oligopeptide covalently bonded with an active agent ( therapeutical agent, contrast agent or fluorescent dye) from a side chain of the intermediate or C-terminus amino acid |
| 02/13/2007 | US7176182 Methods of enhancing functioning of the large intestine |
| 02/13/2007 | US7176181 Enhancement or inhibition of the interactions of galectin-8 and galectin-8-like proteins with other extracellular matrix proteins or cell surface receptors; the use of modulators of cell adhesion; antitumor, -carcinogenic, -metastasis agents |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7176037 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
| 02/13/2007 | US7176036 Electroactive microspheres and methods |
| 02/13/2007 | US7176035 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction |
| 02/13/2007 | US7176033 Increased sensitivity of peptide detection with matrix-assisted laser desorption/ionization mass spectrometry by in vacuo methylation of amino groups |
| 02/13/2007 | US7176032 Process for the polymerisation of isobutene |
| 02/13/2007 | US7176031 Reference control for optical measurement of nucleated red blood cells of a blood sample |
| 02/13/2007 | US7176030 Method and apparatus for ensuring sterility of disposable medical items used with medical equipment |
| 02/13/2007 | US7176020 Detection and monitoring anticarcinogenic agents; obtain tissue, infect with cancer cells, incubate with test compound, monitor antiproliferative activity |
| 02/13/2007 | US7176019 For modulating NF- kappa B signaling |
| 02/13/2007 | US7176016 High throughput method and system for screening candidate compounds for activity against target ion channels |
| 02/13/2007 | US7176014 Solid culture medium and method for preparing the same |
| 02/13/2007 | US7176003 Subjecting a nucleic acid sample to a plurality of amplification reactions to amplify the segments, whrein the time of extension phase in each reaction is varied, monitoring progress of amplification, determing minimum time required |
| 02/13/2007 | US7175993 Taxol immunoassay |
| 02/13/2007 | US7175992 Kits and methods useful in quantitatively measuring the amount of an analyte in a fluid sample by providing a solid phase apparatus comprising a membrane having an application point, a sample capture zone, and a control capture zone |
| 02/13/2007 | US7175991 analyzing binding displacement effect of drugs having binding affinity to serum albumin or acid glycoproteins; receptor binding assay; competitive binding; medical diagnosis |
| 02/13/2007 | US7175990 Prognosticating probability of pregnancy via selectin concentration; in vitro fertilization |
| 02/13/2007 | US7175989 Antibodies to trisulfated heparin disaccharide in painful sensory axonal neuropathy |
| 02/13/2007 | US7175988 Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
| 02/13/2007 | US7175986 labeling proteins and other molecules such as lipid and carbohydrates in different samples, then combining these samples for concurrent analysis, for reliable qualitative and quantitative comparison between the samples |
| 02/13/2007 | US7175984 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
| 02/13/2007 | US7175983 Adapter-directed display systems |
| 02/13/2007 | US7175981 Diagnosing prostate and mammary gland cancer; obtain cells, measure concentration of fatty acid binding protein in sample, compare to control, evaluate for cancer |
| 02/13/2007 | US7175980 Method of making a plastic colorimetric resonant biosensor device with liquid handling capabilities |
| 02/13/2007 | US7175912 Magnetic core particles selected from magnetite, diiron trioxide, bivalent ferrites of manganese, nickel, zinc, and/or copper; shell comprising noble metal; coprecipitation and depositing gold or silver to coat by chemical reduction |
| 02/13/2007 | US7175885 Combinatorial approach for preparing arrays of chemically sensitive polymer-based sensors which are capable of detecting the presence of a chemical analyst in a fluid in contact therewith |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |
| 02/13/2007 | US7175846 Cancerous disease modifying antibodies |
| 02/13/2007 | US7175844 Administering an agent that inhibits a component of the VEGF signal transduction pathway; agent decreases a connective tissue growth factor (CTGF) activity in the tissue of the subject. |
| 02/13/2007 | US7175842 Methods of modulating hair growth |
| 02/13/2007 | US7175811 Reaction matrix; for use in the generation of fluorescent signals in sample |
| 02/13/2007 | US7175810 Processing of particles |
| 02/13/2007 | US7175753 Process and device for monitoring the hydrogen concentration |
| 02/13/2007 | US7175642 Methods and apparatus for lancet actuation |
| 02/13/2007 | US7175430 Support materials and imaging method for intraoral diagnostic purposes |
| 02/13/2007 | US7175089 Face determination |
| 02/13/2007 | US7174798 Alignment device for positioning liquid flow tube |
| 02/13/2007 | US7174797 High temperature and pressure testing facility |
| 02/13/2007 | US7174768 Hydrogen sensor, apparatus for measuring hydrogen concentration, and method for measuring hydrogen concentration |
| 02/13/2007 | CA2510981C Fibrin sealant compositions and methods for utilizing same |
| 02/13/2007 | CA2430714C Ram-air sample collection device for a chemical warfare agent sensor |
| 02/13/2007 | CA2310762C Capillary active test element having an intermediate layer situated between the support and the covering |
| 02/13/2007 | CA2284801C Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| 02/13/2007 | CA2219947C Monoclonal antibody reactive to human cetp and assay method for human cetp |
| 02/13/2007 | CA2217296C Rapid assays for the assessment of organ status based on the detection of one or more isoenzymes of glutathione s-transferase |
| 02/13/2007 | CA2124958C Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 02/13/2007 | CA2123241C Nucleosides and oligonucleotides having 2'ether groups |
| 02/13/2007 | CA2084987C Nucleic acid ligands |
| 02/12/2007 | CA2555979A1 Factor xa-based heparin assay using a heparin-modifying component |
| 02/12/2007 | CA2553115A1 Modulation of peroxisome proliferation-activated receptors |
| 02/10/2007 | CA2555621A1 Sample pick-up and metering device with integrated liquid compartments |
| 02/09/2007 | CA2552596A1 Methods and systems for determining mid-value titers |
| 02/08/2007 | WO2007016644A1 Screening method for identification of compounds suitable for treatment of oral cavity malodor associated with consumption of garlic |
| 02/08/2007 | WO2007016633A1 Apparatus assembly and method for detecting an analyte |
| 02/08/2007 | WO2007016619A2 Screening method for the identification of compositions suitable for the treatment of oral cavity malodor associated with smoking a tobacco product |
| 02/08/2007 | WO2007016591A2 Compositions and methods for monitoring and altering protein folding and solubility |
| 02/08/2007 | WO2007016529A2 Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy |
| 02/08/2007 | WO2007016453A2 Systems and methods for capture substrates |
| 02/08/2007 | WO2007016432A2 Apparatus and method for coupling microfluidic systems with a mass spectrometer utilizing rapid voltage switching |
| 02/08/2007 | WO2007016379A2 Method for improving cell permeability to foreign particles |
| 02/08/2007 | WO2007016357A1 Amyloid beta receptor and uses thereof |
| 02/08/2007 | WO2007016309A2 Method to determine predictive tests and device applying same to lubricant formulations |
| 02/08/2007 | WO2007016263A1 Transgenic non-human animal model of lung tumorigenesis |
| 02/08/2007 | WO2007016257A2 Method for evaluating drug candidates |
| 02/08/2007 | WO2007016164A2 Cat1 transporters expressed in blood brain barrier cells |
| 02/08/2007 | WO2007016161A2 Oct3 transporters expressed in blood brain barrier cells |
| 02/08/2007 | WO2007016159A2 Gat2 transporters expressed in blood brain barrier cells |
| 02/08/2007 | WO2007016157A2 Methods and apparatus for identifying live eggs |
| 02/08/2007 | WO2007015926A2 Multiparameter flow cytometric cytometric cytotoxicity systems, methods, compositions and kits for evaluating the susceptibility of cancer |
| 02/08/2007 | WO2007015914A2 Methods and apparatus for maintaining effective operation of apparatus for candling avian eggs |
| 02/08/2007 | WO2007015886A2 Phosphorylated protein markers of gleevec-resistant chronic myelogenous leukemia |
| 02/08/2007 | WO2007015840A2 Reagents for the detection of phosphorylated atr kinase (ser 428/ser 2317) and uses thereof |
| 02/08/2007 | WO2007015697A2 Method for enhancing two-dimensional gel electrophoresis resolution |
| 02/08/2007 | WO2007015690A1 Protein/peptide sequencing by chemical degradation in the gas phase |
| 02/08/2007 | WO2007015587A1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent |
| 02/08/2007 | WO2007015578A1 Method for assay on the effect of vascularization inhibitor |
| 02/08/2007 | WO2007015569A1 Method for prediction of the efficacy of vascularization inhibitor |
| 02/08/2007 | WO2007015540A1 Cytotoxic t-cell epitope peptide and use thereof |
| 02/08/2007 | WO2007015509A1 Immunoassay reagent |
| 02/08/2007 | WO2007015377A1 Method of detecting ricin, kit and sensor chip for detecting ricin |